Serum levels of glial fibrillary acidic protein and Nogo-A in children with autism spectrum disorders

Abstract

It will be of great interest to determine other potential causes of elevated serum levels of GFAP, and whether this elevation has any phenotypic effect.

Serum levels of Glial fibrillary acidic protein in Chinese children with autism spectrum disorders

“…To our knowledge this is the first analysis to report the presence of serum levels of GFAP in ASD and typical development children in Chinese population. Inconsistent with the results of our research, a previous study finished by Cetin et al (2016) found that the mean serum levels of GFAP were significantly lower in ASD than controls (141.7 pg/ml VS. 428.5 pg/ml). Furthermore, Kirkman et al (2008) reported that there was no significant difference of GFAP between autism and controls.…”

Evaluation of serum Neuron‐specific enolase, S100B, myelin basic protein and glial fibrilliary acidic protein as brain specific proteins in children with autism spectrum disorder

“…GFAP serum levels have been assessed in a study by Çetin et al (Cetin et al, 2016). According to this study, serum GFAP levels in ASD patients were lower compared to a healthy control group.…”

Fourier Transform Infrared Spectroscopy Based Complementary Diagnosis Tool for Autism Spectrum Disorder in Children and Adolescents

“…Body fluids are easy to collect, and their analysis is less expensive compared to neuroimaging and genome studies. Recent studies show that blood samples are one of the most promising targets to search for characteristic biomarkers for ASD, not only due to their easy accessibility but also because of their important biological information content on the health status of children with this disorder [1,4,[9][10][11][12][13][14][15][16][17].…”